카지노 꽁 머니 히트뉴스

카지노 꽁 머니 Biologics, represented by CEO Won-Jik Lee, announced on October 4th that they have signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ), led by Director Jin-Young Kim. The agreement paves the way for the construction of a cutting-edge bio plant within the Incheon Songdo International City.

The signing ceremony, a momentous occasion, took place at the EBC Center on the 113th floor of the iconic 카지노 꽁 머니 World Tower. It was graced by the presence of Won-Jik Lee, the CEO of 카지노 꽁 머니 Biologics, Jin-Young Kim, the Director of IFEZ, and representatives from both organizations.

Under this significant agreement, 카지노 꽁 머니 Biologics is set to establish three bio plants in the KI20 block of Songdo's 11th district by 2030, boasting a remarkable total production capacity of 360,000 liters of antibody drugs. Each plant is designed to produce 120,000 liters of antibody drugs, with consideration given to the addition of small-scale bioreactor and finished pharmaceutical facilities for clinical material production.

The 1st, 2nd, and 3rd plants are scheduled for completion in 2025, 2027, and 2030, with full operation targeted for 2034. Based on the 2034 benchmark, 카지노 꽁 머니 Biologics anticipates reaching a total production capacity of 400,000 liters. The company has outlined its plans to break ground for the 1st plant in the first quarter of 2024, following the completion of permitting processes, collaboration with subcontractors, and selection processes, with project completion slated for the end of 2025.

In a strategic move, 카지노 꽁 머니 Biologics intends to establish a 'Bio-Venture Initiative' within the bio plant complex, dedicated to nurturing bio ventures. This initiative encompasses three core programs:

① Incubating Program: Providing shared laboratories and research equipment, among other resources.

②Accelerating Program: Offering technical support in equipment, IND filing, and commercialization through collaborations with global equipment manufacturers, accelerator firms, and strategic consulting for technology transfer.

③ Support Program: Facilitating connections with investors and delivering consulting services related to legal and accounting matters.

Additionally, leveraging their expertise as a Contract Development and Manufacturing Organization (CDMO), 카지노 꽁 머니 Biologics will institute specialized training programs for resident companies, focusing on process development and CMC document preparation. They also intend to establish a cooperative hiring system involving educational institutions, industry stakeholders, and research institutions in the Incheon region.

카지노 꽁 머니 Biologics emphasizes that through partnerships with outstanding South Korean bio ventures, they aim to enhance their research and development (R&D) capabilities, thus diversifying their portfolio of new drug developments. Furthermore, by attracting Bio-Venture Initiative resident companies to Songdo, they aspire to play a pivotal role in positioning Songdo as a global bio hub.

카지노 꽁 머니 Biologics regards Songdo as a vital asset in their pursuit of corporate goals. Their vision includes establishing global pharmaceutical production standards and attracting new clients. The company underscores Songdo's strategic advantages, including its proximity to Incheon International Airport, Incheon Port, robust metropolitan infrastructure, and vibrant bio cluster, positioning it as an ideal base for their medium to long-term objectives.

CEO Won-Jik Lee expressed his excitement about shaping 카지노 꽁 머니 Biologics' future in Songdo International City, a global bio cluster that transcends national boundaries. He stated, "We are fully committed to the seamless execution of the bio plant construction, solidifying our position as a trusted partner in the global CDMO market. Our dedication to industry prominence remains unwavering."

Director Jin-Young Kim of the Incheon Free Economic Zone Authority remarked, "With 카지노 꽁 머니 Biologics' commitment to the bio plant construction, Songdo has firmly established itself as a global bio cluster under global scrutiny. We are wholeheartedly dedicated to ensuring the smooth progress of facility construction and business operations in the times ahead."